Zelnorm is a drug approved by the FDA in 2002 for the short-term treatment of women diagnosed with irritable bowel syndrome involving constipation. In 2004, the FDA approved Zelnorm additionally to treat patients under 65 years of age with chronic idiopathic (i.e., unknown origin) constipation. This litigation involves actions seeking damages and/or other relief arising allegedly from the use of Zelnorm.

Privacy Policy | Contact Us | © New Jersey Judiciary